Is Glutamate Sensitivity Real? Myths About Glutamate, MSG: Part 2

Originally Medically Reviewed by Dr. Sony Sherpa, (MBBS) - September 10, 2024

Fact Checked and Updated by Abinaya Muralidharan, M. Pharm - August 11, 2026

Introduction

Glutamate is a vital amino acid that aids normal body function and is naturally present in many foods. Although glutamate and monosodium glutamate (MSG) have long been the subject of safety concerns, current evidence indicates that typical dietary intake is safe for most people. This article examines the research on glutamate safety, potential side effects, factors that may influence glutamate sensitivity, and practical strategies to support healthy glutamate metabolism.

• Part 1 introduces glutamate and its functions in the body, possible benefits, and myths pertaining to MSG consumption.
• Part 2 (below) covers the safety and toxicity of glutamate, possible side effects, risk factors, and tips for supporting optimal glutamate metabolism.

Toxicity & Safety: Are There Side Effects to Consuming Glutamate?

Glutamate can cause short-term adverse effects, but only under specific conditions - not from typical dietary intake.

Free glutamates, in their isolated or concentrated ingredient form - such as MSG powder, hydrolyzed proteins or protein isolates - contain far higher glutamate concentrations than any whole food. However, once diluted into a prepared meal, the resulting free glutamate content is often comparable to, or even lower than, naturally glutamate-rich whole foods. For the general population, dietary intake of glutamate-containing ingredients, whether added or naturally occurring, falls within established safety margins.

Safe and Toxic Glutamate Concentrations

The EFSA's (European Food Safety Authority ) Acceptable Daily Intake is 30 mg/kg body weight/day for regular consumption, while research shows that about 3 grams of MSG on an empty stomach may cause short-term symptoms like headache or flushing in sensitive people, far more than the under 0.5 grams typically found in a serving of food. MSG is one of the most studied forms of free glutamate. Free glutamate is often formed during the processing of other refined flavor-enhancing agents and protein formulations.

ESFA’s comprehensive safety evaluations for MSG toxicity concluded:

• In rodent dietary studies, at doses of up to 5000 mg per kg of body weight per day, there were no adverse effects in rats over a short-term period.
• Single high doses (up to 5250 mg/kg body weight) showed extremely low acute toxicity in animal models.
• A slight increase in kidney or spleen weight at certain high dose levels was not accompanied by tissue damage or an increased risk of disease.
• Newborn rodents were shown to be the most vulnerable to potential adverse effects of MSG due to their developing blood-brain barriers.

Levels considered safe to consume and implemented in food additive legislation are set at a small fraction of the doses evaluated in animal toxicity studies. Average daily MSG consumption across the population has been estimated at roughly 0.3-1 g; well below the doses administered in studies. While protein-hydrolysate baby formulas contain higher levels of free glutamate, research shows that the infant gut processes it safely with no evidence of adverse developmental effects.

While major health organizations deem MSG safe for the general public at standard dietary levels, researchers continue to study long-term, low-dose exposure and effects in specific subgroups to ensure safety guidelines remain up to date.

9 Potential Side Effects of Free Glutamate Overload

MSG research has often yielded inconsistent results. While early human trials showed reactions were often not reproducible, especially when consumed with food, some animal studies point towards the potential for adverse effects, typically due to high doses or direct injections. This highlights the need for more research to clarify interindividual differences in response to free glutamate consumption.

Potential side effects elicited by MSG may include:

• Ferroptosis

In vitro, MSG is capable of promoting ferroptosis, which is a specific type of cell death dependent on iron. Studies show that MSG can induce ferroptosis in neurons.

• Blood pressure

High-dose MSG consumption has been associated with elevated blood pressure in both healthy people and those with hypertension, over a 5-year period. Rat studies confirm these observations, revealing that MSG reduces vasodilation, increases blood clotting factors, and causes the kidneys to retain more sodium.

• Taste perception and craving

A diet high in MSG over the course of a month was shown to diminish the perception of umami taste, the flavor that MSG is able to enhance. This diminishing return was accompanied by a reduced craving for savory foods.

• Hypothalamic lesions

A number of studies have made mention of hypothalamic lesions that developed in lab rats treated with MSG. It has been revealed that a small portion of hypothalamic neurons live just outside the blood-brain barrier and that these neurons are susceptible to MSG-induced neurotoxicity. MSG induced hypothalamic lesions have been linked with reductions in Brain-Derived Neurotrophic Factor (BDNF) in the hypothalamus.

• Improper development

Infantile rats given MSG have been shown to be at a greater risk for developing obesity, neurological deficits, visual problems, and reproductive disorders during their adult lives. During infancy, key hypothalamic regions (such as the arcuate nucleus) sit outside the blood-brain barrier, leaving the vulnerable neurons there exposed to circulating molecules like glutamate. Furthermore, developmental outcomes may result from the effects of MSG on the developing pituitary-hypothalamus axis, which has been shown to induce downstream effects in the thyroid, thymus, adrenal glands, and reproductive organs.

• Innate immune suppression

The innate immune system consists of specialized cells and defense mechanisms present in body tissues. In preclinical rodent studies, MSG has been shown to alter innate immune cell function. MSG-treated rats displayed reduced phagocytic activity and increased oxidative stress in phagocytes and macrophages. Additionally, MSG exposure during infancy has also been shown to suppress cell-mediated immune responses in mice and rats, including reduced responsiveness of spleen cells when tested in vitro.

• Immune cell aggravation

In vitro and animal studies using very high doses of MSG (often through direct injections or experimental concentrations) suggest that MSG may increase inflammatory immune cell activity and reduce levels of some anti-inflammatory compounds. At large enough concentrations, laboratory assay results reveal that MSG can induce gene damage in lymphocytes and lead to cell death. MSG also increased the rate of thymus atrophy, indicative of age-related immune changes in treated animals. However, these findings have not been consistently demonstrated in humans consuming typical dietary amounts of MSG.

• Insulin resistance

While not documented in all rat studies, some studies revealed that MSG can induce insulin resistance, accompanied by faulty fat metabolism, while a separate study using dietary MSG found reduced pancreatic β-cell mass with fibrosis, though without affecting insulin or glucose tolerance. This suggests that while high-dose glutamate in animal models may increase the risk of diabetes and other metabolic disorders, human clinical studies show no evidence that normal dietary MSG increases the risk of insulin resistance.

• Oxidative stress and inflammation

In animal studies and in vitro, MSG has been shown to promote oxidative stress and related inflammation in a number of tissues. These include the brain, liver, kidney, spleen, and thymus. In large doses, the inflammation is capable of inducing pathological changes in these tissues. However, nutrients have been shown to offset the inflammation induced by high-dose MSG through increasing cellular antioxidant levels.

Risk Factors for Glutamate Sensitivity

Any factor that disrupts the regulation of glutamate in the body may contribute to increased susceptibility to adverse reactions from glutamate exposure, though controlled studies have not consistently confirmed reactions attributed to glutamate sensitivity.

Glutamate levels across tissues are kept in balance by several mechanisms, including transport out of cells, conversion to other molecules, and use in ongoing cellular reactions. If it cannot perform a function due to a deficiency of a cofactor in a reaction that normally uses glutamate, there may be an excess of glutamate available. This may then lend itself to promoting an imbalance in another area of cellular metabolism. In neurons, that may manifest as glutamate-induced excitotoxicity. In other body tissues, it may promote an increase in cellular activity linked to inflammation, though its role in promoting tissue growth is not well established.

Small increases and decreases in glutamate levels are natural and not likely to be of any concern unless fluctuations fall outside of healthy ranges. While unproven clinically, chronic cellular deficits in metabolism could alter glutamate dynamics and potentially contribute to glutamate sensitivity in certain individuals.

Glutamate Sensitivity Risk Factors may include:

• Folate deficiency

This may increase the risk for glutamate sensitivity, as folate in the nervous system is chemically bound to glutamate, and folate deficiency is associated with elevated glutamate-related activity. Severe folate deficiency can increase homocysteine levels and promote blood-brain barrier permeability, potentially allowing for blood glutamate to enter the brain. Folate reduces homocysteine levels and has been shown to protect against glutamate-induced excitotoxicity. Folate and glutamate are both naturally present in dietary sources, but adding MSG as a flavor enhancer at dietary levels does not disrupt the body’s nutrient balance.

• Glutamine deficiency

Glutamate in the body is additionally regulated by glutamine. A higher glutamine-to-glutamate ratio is associated with better overall metabolic health. Low plasma glutamine levels reflect metabolic stress and are associated with increased diabetes risk, alcohol-related liver diseases, poorer outcomes in cancer or cardiovascular conditions, and higher all-cause mortality. There is no current evidence that a person’s glutamine status affects their sensitivity to free dietary glutamates. The majority of ingested glutamate is metabolized in the intestine, where it is broken down for energy and used to synthesize other amino acids.

• Hyperammonemia

A high-protein diet may be contraindicated in those with hyperammonemia, who are prone to elevated ammonia and glutamine in the bloodstream. This is because the breakdown of glutamate from dietary protein releases free ammonia in the liver. Consequently, carefully controlling and restricting protein intake remains a primary strategy to manage symptoms.

• Symptomatic individuals

There is a trend for participants across studies to respond negatively to MSG if they already suffered from symptoms known to the MSG symptom complex. For instance, frequent migraine sufferers were more likely than other participants to acquire a headache from consuming MSG-enriched foods. This suggests that MSG may increase the severity of a pre-existing problem or may be unrelated. While further research is required to clarify this concern, those who suffer from frequent headaches, gastrointestinal upsets, skin flushing, as well as musculoskeletal disorders may be at an increased risk for glutamate sensitivity, though findings are inconsistent.

• Neurodegenerative diseases

While neurodegenerative disorders involve impaired glutamate management within the brain, dietary free glutamate does not worsen these conditions. Preclinical studies linking MSG to neurodegenerative diseases used extreme, massive doses that do not reflect human dietary intake. In some individuals, MSG has the potential to promote a rise in blood glutamate concentrations. Although altered brain glutamate metabolism and increased blood-brain permeability are common to these diseases, the gastrointestinal tract metabolizes 95% of ingested glutamate, preventing significant elevations in systemic plasma levels when glutamate is consumed as part of a meal. Under normal, healthy blood-brain barrier function, active transporters move glutamate out of the brain and into the blood, protecting central glutamate levels from dietary intake. Whether this clearance mechanism works effectively when the barrier is compromised, as in some neurodegenerative diseases, isn't well established yet.

• Epilepsy and seizure disorders

As discussed in Part 1, individuals with epilepsy and seizures may already have a disrupted glutamate-GABA balance and altered blood-brain barrier (BBB) permeability. Dietary glutamate may also reach the brain indirectly through gut-nerve signaling and possibly through shifts in gut microbiota, though evidence for dietary glutamate directly altering the human gut microbiome remains inconsistent and is based mainly on animal studies at doses higher than dietary levels. Overall, the direct evidence linking dietary glutamate to seizures remains limited. It is drawn mainly from animal studies using non-dietary, high-dose administration, and the only human trial of a low-glutamate diet in pediatric epilepsy found no significant reduction in seizure frequency. This remains an active research area, not an established risk.

• Insulin resistance

Human research on dietary MSG and insulin resistance or metabolic syndrome risk is mixed; some population studies have found an association, while others have not. Most reported adverse metabolic effects occur at doses far exceeding typical dietary intake. While hypertriglyceridemia, low HDL cholesterol, and chronic stress are established risk factors associated with insulin resistance, individuals with metabolic conditions do not need to restrict free glutamates for glycemic control.

• Liquid administration

While the evidence for MSG symptom complex in typical meals remains inconsistent, limited data indicate that MSG taken in liquid form without food has a higher propensity for eliciting adverse reactions in sensitive individuals, at lower quantities. Liquids are known to be absorbed more quickly than solids, producing a faster and higher peak concentration in the bloodstream, and studies evaluating MSG fortification confirm that liquid food matrices lead to faster systemic glutamate absorption than solid food matrices.

• Infrequent consumption

In clinical challenge trials, individuals who reported symptoms after an initial MSG dose frequently showed no reaction when re-challenged with the same dose, demonstrating that reported reactions are largely inconsistent rather than reproducible. More research is required to understand the association between frequent consumption and subjective symptoms like headache.

• Age and gender

Evidence on whether men and women differ in their response to MSG is limited and inconclusive. While high-dose parenteral animal studies historically showed increased sensitivity in newborn rodents due to an immature blood-brain barrier, human infants possess an intact blood-brain barrier at birth and metabolize dietary glutamate efficiently.

Supporting Optimal Glutamate Metabolism

Dietary glutamate is difficult to avoid because it naturally occurs in nearly all protein-containing foods. Added glutamate also need not be avoided completely, since consuming it as part of a meal - rather than alone- substantially blunts the rise in plasma glutamate, as the body efficiently metabolizes dietary glutamate in the gut and liver. This implies consuming a balanced diet plan that enhances health and well-being.

A few specific nutrients that were proven to protect against MSG toxicity in animal models include:

• Optimal omega-3:omega-6 ratio. Supplementation of omega-3 and 6 in the right ratios to breast-feeding mice protected suckling offspring from MSG-induced obesity, metabolic imbalances, and developmental deficits.
• Tannins. Tannic acid, a type of tannin, has been shown to protect against MSG-induced inflammatory changes and oxidative stress in rats. Red wine, teas, and some herbs are particularly rich in tannins, though these studies used purified, high-dose tannic acid rather than these dietary sources directly.
• Alpha-tocopherol is possibly protective against MSG-induced kidney toxicity and oxidative stress in rats. Dietary sources include nuts and seeds.
• Floral extracts may offset some of the adverse effects of MSG-induced oxidative stress and excitotoxic neuronal damage in rats, primarily through antioxidant pathways. Some floral extracts, such as chamomile, contain lipid-soluble flavonoids (like apigenin) that cross the blood-brain barrier and directly activate central GABA receptors.

Protein-rich foods such as meat, fish, and dairy contain higher concentrations of bound glutamate, which are absorbed more gradually, serving to minimize potential reactions. Some fruits and vegetables, including tomatoes and potatoes, are natural sources of free glutamate. Therefore, sensitive individuals may benefit from tracking total free glutamate intake from both natural and refined sources, rather than assuming that whole food sources are free of it.

Conclusion

Glutamate is an amino acid vital to regulating many bodily functions and is widely present in the human diet in both free and bound forms. At normal dietary intake levels, the majority of those consuming glutamate do not experience adverse reactions. This is supported, in part, by first-pass intestinal metabolism, which regulates the entry of dietary glutamate into systemic circulation under normal physiological conditions.

However, free glutamates, inclusive of MSG, have been associated with self-reported, non-allergenic symptoms in a small subset of sensitive individuals. The occurrence and severity of symptoms are variable and cannot be predicted. Based on current evidence, infants as well as individuals with neurological, metabolic, or cardiovascular diseases and/or nutritional deficiencies have not been shown to be at an increased risk for glutamate sensitivity.

To search for the best Gastroenterology Healthcare Providers and Doctors in Germany, India, Malaysia, Spain, Thailand, Turkey, the UAE, and the USA, please use the Mya Care search engine.

To search for the best doctors and healthcare providers worldwide, please use the Mya Care search engine.

 

First Published: June 01, 2022

References:

Show More ▼